Technical Analysis for ARCT - Arcturus Therapeutics Ltd.

Grade Last Price % Change Price Change
grade D 5.3 6.00% 0.30
ARCT closed up 6.0 percent on Monday, March 18, 2019, on 1.72 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical ARCT trend table...

Date Alert Name Type % Chg
Mar 18 20 DMA Support Bullish 0.00%
Mar 18 Crossed Above 50 DMA Bullish 0.00%
Mar 15 50 DMA Resistance Bearish 6.00%
Mar 15 20 DMA Support Bullish 6.00%
Mar 15 MACD Bullish Signal Line Cross Bullish 6.00%
Mar 14 Fell Below 50 DMA Bearish 6.64%
Mar 14 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 6.64%
Mar 14 20 DMA Support Bullish 6.64%
Mar 14 Spinning Top Other 6.64%
Mar 14 Inside Day Range Contraction 6.64%

Older signals for ARCT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Alcobra Ltd is a development-stage biopharmaceutical company. The Company is focused on development and commercialization of its lead product candidates, including MDX and ADAIR. MDX is a oral drug, for the treatment of ADHD and other cognitive disorders, including Fragile X. MDX is a combined rapid onset ER formulation of the chemical pyridoxine pyroglutamate, which is more commonly known as metadoxine. MDX consists of a single bi-layer oral tablet, which includes both a rapid onset release metadoxine formulation and a slow release metadoxine formulation together providing the desired dual release profile. The new extended-release formulation prolongs the human plasma levels of metadoxine for up to 12 hours, which results in enhanced efficacy benefits. ADAIR is an oral, semi-solid, liquid-filled, hard gelatin capsule of an abuse-deterrent IR formulation of dextroamphetamine sulfate, which is manufactured as 10 mg capsules.
Biopharmaceutical Pharmaceutical Industry Drugs Pharmacology Health Sciences Euphoriants Dosage Forms Adhd Cognitive Disorders Tablet Taar1 Agonists
Is ARCT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.0
52 Week Low 4.11
Average Volume 42,004
200-Day Moving Average 6.7599
50-Day Moving Average 5.0165
20-Day Moving Average 4.95
10-Day Moving Average 4.8591
Average True Range 0.4122
ADX 15.55
+DI 22.7107
-DI 15.6523
Chandelier Exit (Long, 3 ATRs ) 4.5034
Chandelier Exit (Short, 3 ATRs ) 5.4916
Upper Bollinger Band 5.4323
Lower Bollinger Band 4.4677
Percent B (%b) 0.86
BandWidth 19.486869
MACD Line -0.0062
MACD Signal Line -0.04
MACD Histogram 0.0338
Fundamentals Value
Market Cap 840.02 Million
Num Shares 158 Million
EPS -0.56
Price-to-Earnings (P/E) Ratio -9.46
Price-to-Sales 11.42
Price-to-Book 2.04
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.23
Resistance 3 (R3) 6.16 5.77 6.08
Resistance 2 (R2) 5.77 5.54 5.81 6.02
Resistance 1 (R1) 5.54 5.39 5.66 5.61 5.97
Pivot Point 5.15 5.15 5.21 5.19 5.15
Support 1 (S1) 4.92 4.92 5.04 4.99 4.63
Support 2 (S2) 4.53 4.77 4.57 4.58
Support 3 (S3) 4.30 4.53 4.53
Support 4 (S4) 4.37